Selected article for: "high throughput and protein expression"

Author: Rappuoli, Rino; Bottomley, Matthew J.; D’Oro, Ugo; Finco, Oretta; De Gregorio, Ennio
Title: Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
  • Document date: 2016_4_4
  • ID: uyoerxvu_8
    Snippet: 2000: The first vaccine candidates based on antigens discovered by genomics are reported (Pizza et al., 2000) . Reverse vaccinology 2.0 Genomics, high-throughput protein expression, animal models, human monoclonals, B cell repertoire deep sequencing, proteomics, and structure-based antigen design: Genomics is used not only for antigen discovery, but also for antigen expression, conservation, and for epidemiology. Human monoclonals are used to ide.....
    Document: 2000: The first vaccine candidates based on antigens discovered by genomics are reported (Pizza et al., 2000) . Reverse vaccinology 2.0 Genomics, high-throughput protein expression, animal models, human monoclonals, B cell repertoire deep sequencing, proteomics, and structure-based antigen design: Genomics is used not only for antigen discovery, but also for antigen expression, conservation, and for epidemiology. Human monoclonals are used to identify protective antigens/epitopes. Structural characterization of the Ab-antigen complex is used to instruct antigen design.

    Search related documents:
    Co phrase search for related documents
    • Ab antigen complex and protective antigen epitope: 1
    • Ab antigen complex and structural characterization: 1
    • animal model and antigen design: 1
    • animal model and antigen expression: 1, 2, 3
    • animal model and cell repertoire: 1, 2
    • animal model and deep sequencing: 1, 2
    • animal model and high throughput: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • animal model and human monoclonal: 1, 2, 3, 4, 5, 6, 7, 8
    • animal model and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • animal model and structural characterization: 1
    • animal model and vaccine candidate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • antigen design and high throughput: 1, 2, 3, 4, 5, 6
    • antigen design and human monoclonal: 1, 2, 3
    • antigen design and protein expression: 1, 2, 3, 4
    • antigen design and reverse vaccinology: 1, 2, 3
    • antigen design and vaccine candidate: 1, 2, 3, 4, 5, 6, 7
    • antigen epitope and high throughput: 1, 2, 3, 4
    • antigen epitope and protective antigen epitope: 1
    • antigen epitope and protein expression: 1